Protagonist Therapeutics PTGX Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's other operating expenses?
- Protagonist Therapeutics (PTGX) reported other operating expenses of $60.02M in Q1 2026.
- How has Protagonist Therapeutics's other operating expenses changed year-over-year?
- Protagonist Therapeutics's other operating expenses increased by 26.0% year-over-year, from $47.63M to $60.02M.
- What is the long-term trend for Protagonist Therapeutics's other operating expenses?
- Over 4 years (2021 to 2025), Protagonist Therapeutics's other operating expenses has grown at a 7.4% compound annual growth rate (CAGR), from $153.2M to $204.14M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.